Skip to main content

Paclitaxel News

Dostarlimab + Chemo Beneficial for Advanced, Recurrent Endometrial Cancer

MONDAY, June 9, 2025 – For patients with advanced or recurrent endometrial cancer, dostarlimab plus carboplatin-paclitaxel treatment is associated with improved survival and maintenance of quality...

New Drug Regimen Extends Survival for Cervical Cancer Patients

THURSDAY, Oct. 17, 2024 – In some good news for women battling locally advanced cervical cancer, new research shows that adding six weeks of chemotherapy to standard treatment cuts the risk of death...

FDA Grants Genentech’s Tecentriq in Combination With Abraxane Accelerated Approval for People With PD-L1-Positive, Metastatic Triple-Negative Breast Cancer

South San Francisco, CA – March 8, 2019 – Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced the U.S. Food and Drug Administration (FDA) has granted accelerated...

FDA Approves Cyramza (ramucirumab) in Combination with Paclitaxel for Advanced Gastric Cancer after Prior Chemotherapy

INDIANAPOLIS, Nov. 5, 2014 /PRNewswire/ – Eli Lilly and Company (NYSE: LLY) announced today that the U.S. Food and Drug Administration (FDA) has approved Cyramza (ramucirumab) in combination with...

FDA Approves Abraxane for the First-Line Treatment of Advanced Non-Small Cell Lung Cancer

SUMMIT, N.J.--(BUSINESS WIRE)--Oct 12, 2012 - Celgene Corporation today announced the U.S. Food and Drug Administration (FDA) has approved Abraxane (paclitaxel protein-bound particles for injectable...

FDA Medwatch Alert: Hospira Injectable Drug Products: Recall - Visible Particulates from Defective Glass Vials

Including certain lots of the following products: carboplatin cytarabine paclitaxel methotrexate [Posted 07/16/2012] ISSUE: Hospira and FDA notified healthcare professional of a nationwide recall...

Ask a question

To post your own question to our community, sign in or create an account.

Further information

Related condition support groups

Breast Cancer, Metastatic, Breast Cancer, Breast Cancer - Adjuvant, Non-Small Cell Lung Cancer, Ovarian Cancer

Paclitaxel patient information at Drugs.com